List of ProLynx patents

List of ProLynx patents

List of Aphios patents

List of Eagle Pharmaceuticals, Inc. patents

List of Seektech patents

List of companies in Warburg Pincus's investment portfolio

List of companies in REDO Ventures's investment portfolio

Patents where

Current Assignee

Name

is

‌

ProLynx

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 8946405 Controlled release from solid supports	Patent 8946405 was granted and assigned to ProLynx on February, 2015 by the United States Patent and Trademark Office.		‌ ProLynx		United States Patent and Trademark Office	8946405	February 3, 2015
	‌ US Patent 8703907 Controlled drug release from dendrimers	Patent 8703907 was granted and assigned to ProLynx on April, 2014 by the United States Patent and Trademark Office.		‌ ProLynx		United States Patent and Trademark Office	8703907	April 22, 2014
	‌ US Patent 9387254 Prodrugs and drug-macromolecule conjugates having controlled drug release rates	Patent 9387254 was granted and assigned to ProLynx on July, 2016 by the United States Patent and Trademark Office.	‌ ProLynx	‌ ProLynx		United States Patent and Trademark Office	9387254	July 12, 2016
	‌ US Patent 8754190 Controlled release from macromolecular conjugates	Patent 8754190 was granted and assigned to ProLynx on June, 2014 by the United States Patent and Trademark Office.		‌ ProLynx		United States Patent and Trademark Office	8754190	June 17, 2014
	‌ US Patent 10413594 Conjugates of somatostatin analogues	Patent 10413594 was granted and assigned to ProLynx on September, 2019 by the United States Patent and Trademark Office.	‌ ProLynx	‌ ProLynx		United States Patent and Trademark Office	10413594	September 17, 2019
	‌ US Patent 10086049 Conjugates of somatostatin analogues	Patent 10086049 was granted and assigned to ProLynx on October, 2018 by the United States Patent and Trademark Office.	‌ ProLynx	‌ ProLynx		United States Patent and Trademark Office	10086049	October 2, 2018
	‌ US Patent 10342792 Slow-release conjugates of SN-38	Patent 10342792 was granted and assigned to ProLynx on July, 2019 by the United States Patent and Trademark Office.	‌ ProLynx	‌ ProLynx		United States Patent and Trademark Office	10342792	July 9, 2019
	‌ US Patent 10398779 Hydrogels with biodegradable crosslinking	Patent 10398779 was granted and assigned to ProLynx on September, 2019 by the United States Patent and Trademark Office.	‌ ProLynx	‌ ProLynx		United States Patent and Trademark Office	10398779	September 3, 2019
	‌ US Patent 11181803 Hydrogels with biodegradable crosslinking	Patent 11181803 was granted and assigned to ProLynx on November, 2021 by the United States Patent and Trademark Office.	‌ ProLynx	‌ ProLynx		United States Patent and Trademark Office	11181803	November 23, 2021
	‌ US Patent 9649385 Hydrogels with biodegradable crosslinking	Patent 9649385 was granted and assigned to ProLynx on May, 2017 by the United States Patent and Trademark Office.		‌ ProLynx		United States Patent and Trademark Office	9649385	May 16, 2017
	‌ US Patent 11179470 Hydrogels with biodegradable crosslinking	Patent 11179470 was granted and assigned to ProLynx on November, 2021 by the United States Patent and Trademark Office.	‌ ProLynx	‌ ProLynx		United States Patent and Trademark Office	11179470	November 23, 2021
	‌ US Patent 10016411 Slow-release conjugates of SN-38	Patent 10016411 was granted and assigned to ProLynx on July, 2018 by the United States Patent and Trademark Office.	‌ ProLynx	‌ ProLynx		United States Patent and Trademark Office	10016411	July 10, 2018

12 results

0 selected

12 results

0 selected